A high-throughput DNA methylation analysis of a single cell.
In recent years, the field of epigenetics has grown dramatically and has become one of the most dynamic and fast-growing branches of molecular biology. The amount of diseases suspected of being influenced by DNA methylation is rising steadily and includes common diseases such as schizophrenia, bipolar disorder, Alzheimer's disease, diabetes, atherosclerosis, cancer, major psychosis, lupus and Parkinson's disease. Due to cellular heterogeneity of methylation patterns, epigenetic analyses of single cells become a necessity. One rationale is that DNA methylation profiles are highly variable across individual cells, even in the same organ, dependent on the function of the gene, disease state, exposure to environmental factors (e.g. radiation, drugs or nutrition), stochastic fluctuations and various other causes. Using a polymerase chain reaction (PCR)-slide microreaction system, we present here a methylation-sensitive PCR analysis, the restriction enzyme-based single-cell methylation assay (RSMA), in the analysis of DNA methylation patterns in single cells. This method addresses the problems of cell heterogeneity in epigenetics research; it is comparably affordable, avoids complicated microfluidic systems and offers the opportunity for high-throughput screening, as many single cells can be screened in parallel. In addition to this study, critical principles and caveats of single cell methylation analyses are discussed.
Beckman Coulter Biomedical GmbH, Advalytix Products, Munich, Germany.
Martin
M
Kantlehner
Roland
R
Kirchner
Petra
P
Hartmann
Joachim W
JW
Ellwart
Marianna
M
Alunni-Fabbroni
Axel
A
Schumacher
D002460:Cell Line; D045744:Cell Line, Tumor; D018899:CpG Islands; D019175:DNA Methylation; D004262:DNA Restriction Enzymes; D057166:High-Throughput Screening Assays; D006801:Humans; D008214:Lymphocytes / Q000378:metabolism; D016133:Polymerase Chain Reaction; D059010:Single-Cell Analysis
D004262:DNA Restriction Enzymes
Cancer Res. 2003 Apr 15;63(8):1789-97
12702564
Am J Hum Genet. 2008 Mar;82(3):696-711
18319075
Carcinogenesis. 2000 Nov;21(11):2057-64
11062168
Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19272-7
17159153
Nat Med. 2009 Sep;15(9):1010-2
19734877
Int J Oncol. 2009 Jun;34(6):1593-602
19424577
Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10604-9
16009939
Cancer Res. 1995 Oct 15;55(20):4525-30
7553621
Nucleic Acids Res. 2005 Apr 28;33(8):e73
15860770
Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20173-8
19075237
Lab Chip. 2007 Apr;7(4):423-40
17389958
J Neurosci Methods. 2008 Sep 15;174(1):123-5
18656499
Nucleic Acids Res. 2006 Jan 20;34(2):528-42
16428248
Science. 2001 Jul 6;293(5527):95-7
11441181
Eur J Cancer. 2005 May;41(8):1185-94
15911243
Science. 2000 Mar 3;287(5458):1652-5
10698740
Biol Reprod. 2003 Sep;69(3):902-14
12748125
N Engl J Med. 2005 May 26;352(21):2211-21
15917386
Curr Top Microbiol Immunol. 2006;310:81-115
16909908
Nature. 2008 Mar 6;452(7183):112-5
18322535
Nat Med. 1995 Jul;1(7):686-92
7585152
Science. 2009 Jun 26;324(5935):1670-3
19556499
Biol Reprod. 2009 Jan;80(1):194-202
18784354
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9160-4
15967986
Nucleic Acids Res. 2001 Nov 1;29(21):E106-6
11691943
Cancer Res. 1976 Dec;36(12):4562-9
1000501
Nucleic Acids Res. 2003 Jul 1;31(13):3406-15
12824337
J Clin Pathol. 2006 Sep;59(9):921-6
16565223
Genome Res. 2009 Jun;19(6):959-66
19273618
J Lipid Res. 2004 Jun;45(6):1162-7
14993237
Anticancer Res. 2005 May-Jun;25(3B):2153-60
16158958
Nucleic Acids Res. 2004 Mar 05;32(4):1566-76
15004243
Nucleic Acids Res. 1994 Aug 11;22(15):2990-7
8065911
Clin Toxicol (Phila). 2010 Feb;48(2):124-8
20199129
BMC Genomics. 2008 Jun 03;9:268
18522723
PLoS One. 2008 Jul 16;3(7):e2698
18628954